2018-2023 Global Drugs for Schistosomiasis Consumption Market Report

July 2018 | 138 pages | ID: 2CC6E37605CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Schistosomiasis market for 2018-2023.

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Drugs for Schistosomiasis is Praziquantel, Oxamniquine and other. Praziquantel is the mainly drug for Schistosomiasis, and the proportion of Praziquantel in 2015 is about 90%.
Drugs for Schistosomiasis are widely used in S. haematobium, S. mansoni, S. japonicum, S. mekongi and S. intercalatum.Most of human infections are caused by S. haematobium, S. mansoni, S. japonicum. And the market share used in S. haematobium in 2015 is 28%. And the market share used in S. mansoni in 2015 is 48%.
Over the next five years, LPI(LP Information) projects that Drugs for Schistosomiasis will register a 5.6% CAGR in terms of revenue, reach US$ 100 million by 2023, from US$ 70 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Schistosomiasis market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Praziquantel
• Oxamniquine
• Other

Segmentation by application:

• S. haematobium
• S. mansoni
• S. japonicum
• S. mekongi
• S. intercalatum

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Shin Poong
• Merck
• Bayer
• EIPICO
• Chandra Bhagat Pharma
• Taj Pharmaceuticals
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Drugs for Schistosomiasis consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Drugs for Schistosomiasis market by identifying its various subsegments.
• Focuses on the key global Drugs for Schistosomiasis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Drugs for Schistosomiasis with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Drugs for Schistosomiasis submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Schistosomiasis Consumption 2013-2023
  2.1.2 Drugs for Schistosomiasis Consumption CAGR by Region
2.2 Drugs for Schistosomiasis Segment by Type
  2.2.1 Praziquantel
  2.2.2 Oxamniquine
  2.2.3 Other
2.3 Drugs for Schistosomiasis Consumption by Type
  2.3.1 Global Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
  2.3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Drugs for Schistosomiasis Sale Price by Type (2013-2018)
2.4 Drugs for Schistosomiasis Segment by Application
  2.4.1 S. haematobium
  2.4.2 S. mansoni
  2.4.3 S. japonicum
  2.4.4 S. mekongi
  2.4.5 S. intercalatum
2.5 Drugs for Schistosomiasis Consumption by Application
  2.5.1 Global Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
  2.5.2 Global Drugs for Schistosomiasis Value and Market Share by Application (2013-2018)
  2.5.3 Global Drugs for Schistosomiasis Sale Price by Application (2013-2018)

3 GLOBAL DRUGS FOR SCHISTOSOMIASIS BY PLAYERS

3.1 Global Drugs for Schistosomiasis Sales Market Share by Players
  3.1.1 Global Drugs for Schistosomiasis Sales by Players (2016-2018)
  3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Players (2016-2018)
3.2 Global Drugs for Schistosomiasis Revenue Market Share by Players
  3.2.1 Global Drugs for Schistosomiasis Revenue by Players (2016-2018)
  3.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Players (2016-2018)
3.3 Global Drugs for Schistosomiasis Sale Price by Players
3.4 Global Drugs for Schistosomiasis Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Drugs for Schistosomiasis Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Drugs for Schistosomiasis Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DRUGS FOR SCHISTOSOMIASIS BY REGIONS

4.1 Drugs for Schistosomiasis by Regions
  4.1.1 Global Drugs for Schistosomiasis Consumption by Regions
  4.1.2 Global Drugs for Schistosomiasis Value by Regions
4.2 Americas Drugs for Schistosomiasis Consumption Growth
4.3 APAC Drugs for Schistosomiasis Consumption Growth
4.4 Europe Drugs for Schistosomiasis Consumption Growth
4.5 Middle East & Africa Drugs for Schistosomiasis Consumption Growth

5 AMERICAS

5.1 Americas Drugs for Schistosomiasis Consumption by Countries
  5.1.1 Americas Drugs for Schistosomiasis Consumption by Countries (2013-2018)
  5.1.2 Americas Drugs for Schistosomiasis Value by Countries (2013-2018)
5.2 Americas Drugs for Schistosomiasis Consumption by Type
5.3 Americas Drugs for Schistosomiasis Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Schistosomiasis Consumption by Countries
  6.1.1 APAC Drugs for Schistosomiasis Consumption by Countries (2013-2018)
  6.1.2 APAC Drugs for Schistosomiasis Value by Countries (2013-2018)
6.2 APAC Drugs for Schistosomiasis Consumption by Type
6.3 APAC Drugs for Schistosomiasis Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Drugs for Schistosomiasis by Countries
  7.1.1 Europe Drugs for Schistosomiasis Consumption by Countries (2013-2018)
  7.1.2 Europe Drugs for Schistosomiasis Value by Countries (2013-2018)
7.2 Europe Drugs for Schistosomiasis Consumption by Type
7.3 Europe Drugs for Schistosomiasis Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Schistosomiasis by Countries
  8.1.1 Middle East & Africa Drugs for Schistosomiasis Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Drugs for Schistosomiasis Value by Countries (2013-2018)
8.2 Middle East & Africa Drugs for Schistosomiasis Consumption by Type
8.3 Middle East & Africa Drugs for Schistosomiasis Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Drugs for Schistosomiasis Distributors
10.3 Drugs for Schistosomiasis Customer

11 GLOBAL DRUGS FOR SCHISTOSOMIASIS MARKET FORECAST

11.1 Global Drugs for Schistosomiasis Consumption Forecast (2018-2023)
11.2 Global Drugs for Schistosomiasis Forecast by Regions
  11.2.1 Global Drugs for Schistosomiasis Forecast by Regions (2018-2023)
  11.2.2 Global Drugs for Schistosomiasis Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Drugs for Schistosomiasis Forecast by Type
11.8 Global Drugs for Schistosomiasis Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Shin Poong
  12.1.1 Company Details
  12.1.2 Drugs for Schistosomiasis Product Offered
  12.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Shin Poong News
12.2 Merck
  12.2.1 Company Details
  12.2.2 Drugs for Schistosomiasis Product Offered
  12.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Merck News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Drugs for Schistosomiasis Product Offered
  12.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 EIPICO
  12.4.1 Company Details
  12.4.2 Drugs for Schistosomiasis Product Offered
  12.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 EIPICO News
12.5 Chandra Bhagat Pharma
  12.5.1 Company Details
  12.5.2 Drugs for Schistosomiasis Product Offered
  12.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Chandra Bhagat Pharma News
12.6 Taj Pharmaceuticals
  12.6.1 Company Details
  12.6.2 Drugs for Schistosomiasis Product Offered
  12.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Taj Pharmaceuticals News

...

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Schistosomiasis
Table Product Specifications of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Report Years Considered
Figure Market Research Methodology
Figure Global Drugs for Schistosomiasis Consumption Growth Rate 2013-2023 (M Units)
Figure Global Drugs for Schistosomiasis Value Growth Rate 2013-2023 ($ Millions)
Table Drugs for Schistosomiasis Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Praziquantel
Table Major Players of Praziquantel
Figure Product Picture of Oxamniquine
Table Major Players of Oxamniquine
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Figure Global Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Table Global Drugs for Schistosomiasis Revenue by Type (2013-2018) ($ million)
Table Global Drugs for Schistosomiasis Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Drugs for Schistosomiasis Value Market Share by Type (2013-2018)
Table Global Drugs for Schistosomiasis Sale Price by Type (2013-2018)
Figure Drugs for Schistosomiasis Consumed in S. haematobium
Figure Global Drugs for Schistosomiasis Market: S. haematobium (2013-2018) (M Units)
Figure Global Drugs for Schistosomiasis Market: S. haematobium (2013-2018) ($ Millions)
Figure Global S. haematobium YoY Growth ($ Millions)
Figure Drugs for Schistosomiasis Consumed in S. mansoni
Figure Global Drugs for Schistosomiasis Market: S. mansoni (2013-2018) (M Units)
Figure Global Drugs for Schistosomiasis Market: S. mansoni (2013-2018) ($ Millions)
Figure Global S. mansoni YoY Growth ($ Millions)
Figure Drugs for Schistosomiasis Consumed in S. japonicum
Figure Global Drugs for Schistosomiasis Market: S. japonicum (2013-2018) (M Units)
Figure Global Drugs for Schistosomiasis Market: S. japonicum (2013-2018) ($ Millions)
Figure Global S. japonicum YoY Growth ($ Millions)
Figure Drugs for Schistosomiasis Consumed in S. mekongi
Figure Global Drugs for Schistosomiasis Market: S. mekongi (2013-2018) (M Units)
Figure Global Drugs for Schistosomiasis Market: S. mekongi (2013-2018) ($ Millions)
Figure Global S. mekongi YoY Growth ($ Millions)
Figure Drugs for Schistosomiasis Consumed in S. intercalatum
Figure Global Drugs for Schistosomiasis Market: S. intercalatum (2013-2018) (M Units)
Figure Global Drugs for Schistosomiasis Market: S. intercalatum (2013-2018) ($ Millions)
Figure Global S. intercalatum YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Figure Global Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Table Global Drugs for Schistosomiasis Value by Application (2013-2018)
Table Global Drugs for Schistosomiasis Value Market Share by Application (2013-2018)
Figure Global Drugs for Schistosomiasis Value Market Share by Application (2013-2018)
Table Global Drugs for Schistosomiasis Sale Price by Application (2013-2018)
Table Global Drugs for Schistosomiasis Sales by Players (2016-2018) (M Units)
Table Global Drugs for Schistosomiasis Sales Market Share by Players (2016-2018)
Figure Global Drugs for Schistosomiasis Sales Market Share by Players in 2016
Figure Global Drugs for Schistosomiasis Sales Market Share by Players in 2017
Table Global Drugs for Schistosomiasis Revenue by Players (2016-2018) ($ Millions)
Table Global Drugs for Schistosomiasis Revenue Market Share by Players (2016-2018)
Figure Global Drugs for Schistosomiasis Revenue Market Share by Players in 2016
Figure Global Drugs for Schistosomiasis Revenue Market Share by Players in 2017
Table Global Drugs for Schistosomiasis Sale Price by Players (2016-2018)
Figure Global Drugs for Schistosomiasis Sale Price by Players in 2017
Table Global Drugs for Schistosomiasis Manufacturing Base Distribution and Sales Area by Players
Table Players Drugs for Schistosomiasis Products Offered
Table Drugs for Schistosomiasis Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Drugs for Schistosomiasis Consumption by Regions 2013-2018 (M Units)
Table Global Drugs for Schistosomiasis Consumption Market Share by Regions 2013-2018
Figure Global Drugs for Schistosomiasis Consumption Market Share by Regions 2013-2018
Table Global Drugs for Schistosomiasis Value by Regions 2013-2018 ($ Millions)
Table Global Drugs for Schistosomiasis Value Market Share by Regions 2013-2018
Figure Global Drugs for Schistosomiasis Value Market Share by Regions 2013-2018
Figure Americas Drugs for Schistosomiasis Consumption 2013-2018 (M Units)
Figure Americas Drugs for Schistosomiasis Value 2013-2018 ($ Millions)
Figure APAC Drugs for Schistosomiasis Consumption 2013-2018 (M Units)
Figure APAC Drugs for Schistosomiasis Value 2013-2018 ($ Millions)
Figure Europe Drugs for Schistosomiasis Consumption 2013-2018 (M Units)
Figure Europe Drugs for Schistosomiasis Value 2013-2018 ($ Millions)
Figure Middle East & Africa Drugs for Schistosomiasis Consumption 2013-2018 (M Units)
Figure Middle East & Africa Drugs for Schistosomiasis Value 2013-2018 ($ Millions)
Table Americas Drugs for Schistosomiasis Consumption by Countries (2013-2018) (M Units)
Table Americas Drugs for Schistosomiasis Consumption Market Share by Countries (2013-2018)
Figure Americas Drugs for Schistosomiasis Consumption Market Share by Countries in 2017
Table Americas Drugs for Schistosomiasis Value by Countries (2013-2018) ($ Millions)
Table Americas Drugs for Schistosomiasis Value Market Share by Countries (2013-2018)
Figure Americas Drugs for Schistosomiasis Value Market Share by Countries in 2017
Table Americas Drugs for Schistosomiasis Consumption by Type (2013-2018) (M Units)
Table Americas Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Figure Americas Drugs for Schistosomiasis Consumption Market Share by Type in 2017
Table Americas Drugs for Schistosomiasis Consumption by Application (2013-2018) (M Units)
Table Americas Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Figure Americas Drugs for Schistosomiasis Consumption Market Share by Application in 2017
Figure United States Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure United States Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Canada Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Canada Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Mexico Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Mexico Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Table APAC Drugs for Schistosomiasis Consumption by Countries (2013-2018) (M Units)
Table APAC Drugs for Schistosomiasis Consumption Market Share by Countries (2013-2018)
Figure APAC Drugs for Schistosomiasis Consumption Market Share by Countries in 2017
Table APAC Drugs for Schistosomiasis Value by Countries (2013-2018) ($ Millions)
Table APAC Drugs for Schistosomiasis Value Market Share by Countries (2013-2018)
Figure APAC Drugs for Schistosomiasis Value Market Share by Countries in 2017
Table APAC Drugs for Schistosomiasis Consumption by Type (2013-2018) (M Units)
Table APAC Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Figure APAC Drugs for Schistosomiasis Consumption Market Share by Type in 2017
Table APAC Drugs for Schistosomiasis Consumption by Application (2013-2018) (M Units)
Table APAC Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Figure APAC Drugs for Schistosomiasis Consumption Market Share by Application in 2017
Figure China Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure China Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Japan Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Japan Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Korea Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Korea Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Southeast Asia Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure India Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure India Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Australia Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Australia Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Table Europe Drugs for Schistosomiasis Consumption by Countries (2013-2018) (M Units)
Table Europe Drugs for Schistosomiasis Consumption Market Share by Countries (2013-2018)
Figure Europe Drugs for Schistosomiasis Consumption Market Share by Countries in 2017
Table Europe Drugs for Schistosomiasis Value by Countries (2013-2018) ($ Millions)
Table Europe Drugs for Schistosomiasis Value Market Share by Countries (2013-2018)
Figure Europe Drugs for Schistosomiasis Value Market Share by Countries in 2017
Table Europe Drugs for Schistosomiasis Consumption by Type (2013-2018) (M Units)
Table Europe Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Figure Europe Drugs for Schistosomiasis Consumption Market Share by Type in 2017
Table Europe Drugs for Schistosomiasis Consumption by Application (2013-2018) (M Units)
Table Europe Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Figure Europe Drugs for Schistosomiasis Consumption Market Share by Application in 2017
Figure Germany Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Germany Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure France Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure France Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure UK Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure UK Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Italy Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Italy Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Russia Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Russia Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Spain Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Spain Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Drugs for Schistosomiasis Consumption by Countries (2013-2018) (M Units)
Table Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Countries in 2017
Table Middle East & Africa Drugs for Schistosomiasis Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Drugs for Schistosomiasis Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Schistosomiasis Value Market Share by Countries in 2017
Table Middle East & Africa Drugs for Schistosomiasis Consumption by Type (2013-2018) (M Units)
Table Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Type in 2017
Table Middle East & Africa Drugs for Schistosomiasis Consumption by Application (2013-2018) (M Units)
Table Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Drugs for Schistosomiasis Consumption Market Share by Application in 2017
Figure Egypt Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Egypt Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure South Africa Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure South Africa Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Israel Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Israel Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure Turkey Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure Turkey Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Drugs for Schistosomiasis Consumption Growth 2013-2018 (M Units)
Figure GCC Countries Drugs for Schistosomiasis Value Growth 2013-2018 ($ Millions)
Table Drugs for Schistosomiasis Distributors List
Table Drugs for Schistosomiasis Customer List
Figure Global Drugs for Schistosomiasis Consumption Growth Rate Forecast (2018-2023) (M Units)
Figure Global Drugs for Schistosomiasis Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Drugs for Schistosomiasis Consumption Forecast by Countries (2018-2023) (M Units)
Table Global Drugs for Schistosomiasis Consumption Market Forecast by Regions
Table Global Drugs for Schistosomiasis Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Drugs for Schistosomiasis Value Market Share Forecast by Regions
Figure Americas Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Americas Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure APAC Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure APAC Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Europe Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Europe Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Middle East & Africa Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Middle East & Africa Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure United States Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure United States Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Canada Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Canada Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Mexico Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Mexico Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Brazil Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Brazil Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure China Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure China Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Japan Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Japan Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Korea Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Korea Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Southeast Asia Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Southeast Asia Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure India Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure India Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Australia Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Australia Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Germany Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Germany Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure France Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure France Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure UK Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure UK Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Italy Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Italy Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Russia Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Russia Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Spain Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Spain Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Egypt Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Egypt Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure South Africa Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure South Africa Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Israel Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Israel Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure Turkey Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure Turkey Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Figure GCC Countries Drugs for Schistosomiasis Consumption 2018-2023 (M Units)
Figure GCC Countries Drugs for Schistosomiasis Value 2018-2023 ($ Millions)
Table Global Drugs for Schistosomiasis Consumption Forecast by Type (2018-2023) (M Units)
Table Global Drugs for Schistosomiasis Consumption Market Share Forecast by Type (2018-2023)
Table Global Drugs for Schistosomiasis Value Forecast by Type (2018-2023) ($ Millions)
Table Global Drugs for Schistosomiasis Value Market Share Forecast by Type (2018-2023)
Table Global Drugs for Schistosomiasis Consumption Forecast by Application (2018-2023) (M Units)
Table Global Drugs for Schistosomiasis Consumption Market Share Forecast by Application (2018-2023)
Table Global Drugs for Schistosomiasis Value Forecast by Application (2018-2023) ($ Millions)
Table Global Drugs for Schistosomiasis Value Market Share Forecast by Application (2018-2023)
Table Shin Poong Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shin Poong Drugs for Schistosomiasis Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Drugs for Schistosomiasis Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Drugs for Schistosomiasis Market Share (2016-2018)
Table EIPICO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure EIPICO Drugs for Schistosomiasis Market Share (2016-2018)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Chandra Bhagat Pharma Drugs for Schistosomiasis Market Share (2016-2018)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Taj Pharmaceuticals Drugs for Schistosomiasis Market Share (2016-2018)